396 related articles for article (PubMed ID: 30321863)
1. Guided tissue engineering for healing of cancellous and cortical bone using a combination of biomaterial based scaffolding and local bone active molecule delivery.
Raina DB; Qayoom I; Larsson D; Zheng MH; Kumar A; Isaksson H; Lidgren L; Tägil M
Biomaterials; 2019 Jan; 188():38-49. PubMed ID: 30321863
[TBL] [Abstract][Full Text] [Related]
2. Gelatin- hydroxyapatite- calcium sulphate based biomaterial for long term sustained delivery of bone morphogenic protein-2 and zoledronic acid for increased bone formation: In-vitro and in-vivo carrier properties.
Raina DB; Larsson D; Mrkonjic F; Isaksson H; Kumar A; Lidgren L; Tägil M
J Control Release; 2018 Feb; 272():83-96. PubMed ID: 29329716
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Response to a Bioactive Biphasic Biomaterial in the Femoral Neck of Osteoporotic Rats.
Raina DB; Širka A; Qayoom I; Teotia AK; Liu Y; Tarasevicius S; Tanner KE; Isaksson H; Kumar A; Tägil M; Lidgren L
Tissue Eng Part A; 2020 Oct; 26(19-20):1042-1051. PubMed ID: 32242474
[TBL] [Abstract][Full Text] [Related]
4. Biomodulation of an implant for enhanced bone-implant anchorage.
Raina DB; Larsson D; Sezgin EA; Isaksson H; Tägil M; Lidgren L
Acta Biomater; 2019 Sep; 96():619-630. PubMed ID: 31301423
[TBL] [Abstract][Full Text] [Related]
5. A facile one-stage treatment of critical bone defects using a calcium sulfate/hydroxyapatite biomaterial providing spatiotemporal delivery of bone morphogenic protein-2 and zoledronic acid.
Raina DB; Matuszewski LM; Vater C; Bolte J; Isaksson H; Lidgren L; Tägil M; Zwingenberger S
Sci Adv; 2020 Nov; 6(48):. PubMed ID: 33246951
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of rhBMP-2 and zoledronic acid using calcium sulfate/hydroxyapatite carrier as a bioactive bone substitute to enhance and accelerate spinal fusion.
Tian X; Vater C; Raina DB; Findeisen L; Matuszewski LM; Tägil M; Lidgren L; Winkler A; Gottwald R; Modler N; Schaser KD; Disch AC; Zwingenberger S
Bioact Mater; 2024 Jun; 36():256-271. PubMed ID: 38487704
[TBL] [Abstract][Full Text] [Related]
7. Modulation of anabolic and catabolic responses via a porous polymer scaffold manufactured using thermally induced phase separation.
Yu NY; Schindeler A; Peacock L; Mikulec K; Fitzpatrick J; Ruys AJ; Cooper-White JJ; Little DG
Eur Cell Mater; 2013 Feb; 25():190-203. PubMed ID: 23444237
[TBL] [Abstract][Full Text] [Related]
8. Spatial control of bone formation using a porous polymer scaffold co-delivering anabolic rhBMP-2 and anti-resorptive agents.
Yu NY; Gdalevitch M; Murphy CM; Mikulec K; Peacock L; Fitzpatrick J; Cantrill LC; Ruys AJ; Cooper-White JJ; Little DG; Schindeler A
Eur Cell Mater; 2014 Jan; 27():98-109; discussion 109-111. PubMed ID: 24488823
[TBL] [Abstract][Full Text] [Related]
9. Calcium Sulphate/Hydroxyapatite Carrier for Bone Formation in the Femoral Neck of Osteoporotic Rats.
Širka A; Raina DB; Isaksson H; Tanner KE; Smailys A; Kumar A; Tarasevičius Š; Tägil M; Lidgren L
Tissue Eng Part A; 2018 Dec; 24(23-24):1753-1764. PubMed ID: 29855219
[TBL] [Abstract][Full Text] [Related]
10.
Horstmann PF; Raina DB; Isaksson H; Hettwer W; Lidgren L; Petersen MM; Tägil M
Tissue Eng Part A; 2017 Dec; 23(23-24):1403-1412. PubMed ID: 28537526
[TBL] [Abstract][Full Text] [Related]
11. Biocomposite macroporous cryogels as potential carrier scaffolds for bone active agents augmenting bone regeneration.
Raina DB; Isaksson H; Teotia AK; Lidgren L; Tägil M; Kumar A
J Control Release; 2016 Aug; 235():365-378. PubMed ID: 27252151
[TBL] [Abstract][Full Text] [Related]
12. Novel microhydroxyapatite particles in a collagen scaffold: a bioactive bone void filler?
Lyons FG; Gleeson JP; Partap S; Coghlan K; O'Brien FJ
Clin Orthop Relat Res; 2014 Apr; 472(4):1318-28. PubMed ID: 24385037
[TBL] [Abstract][Full Text] [Related]
13. Improved union and bone strength in a mouse model of NF1 pseudarthrosis treated with recombinant human bone morphogenetic protein-2 and zoledronic acid.
Deo N; Cheng TL; Mikulec K; Peacock L; Little DG; Schindeler A
J Orthop Res; 2018 Mar; 36(3):930-936. PubMed ID: 28767180
[TBL] [Abstract][Full Text] [Related]
14. Ridge augmentation following implantation of recombinant human bone morphogenetic protein-2 in the dog.
Barboza EP; Duarte ME; Geolás L; Sorensen RG; Riedel GE; Wikesjö UM
J Periodontol; 2000 Mar; 71(3):488-96. PubMed ID: 10776939
[TBL] [Abstract][Full Text] [Related]
15. Nanohydroxyapatite Based Ceramic Carrier Promotes Bone Formation in a Femoral Neck Canal Defect in Osteoporotic Rats.
Qayoom I; Teotia AK; Kumar A
Biomacromolecules; 2020 Feb; 21(2):328-337. PubMed ID: 31637919
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant human bone morphogenetic protein-2 on bone regeneration in large defects of the growing canine skull after dura mater replacement with a dura mater substitute.
He D; Genecov DG; Herbert M; Barcelo R; Elsalanty ME; Weprin BE; Opperman LA
J Neurosurg; 2010 Feb; 112(2):319-28. PubMed ID: 19267528
[TBL] [Abstract][Full Text] [Related]
17. Experimental study of nano-hydroxyapatite/recombinant human bone morphogenetic protein-2 composite artificial bone.
Zhu W; Wang D; Zhang X; Lu W; Han Y; Ou Y; Zhou K; Fen W; Liu J; Peng L; He C; Zeng Y
Artif Cells Blood Substit Immobil Biotechnol; 2010 May; 38(3):150-6. PubMed ID: 20429682
[TBL] [Abstract][Full Text] [Related]
18. Influence of bone morphogenetic protein and proportion of hydroxyapatite on new bone formation in biphasic calcium phosphate graft: two pilot studies in animal bony defect model.
Yun PY; Kim YK; Jeong KI; Park JC; Choi YJ
J Craniomaxillofac Surg; 2014 Dec; 42(8):1909-17. PubMed ID: 25443868
[TBL] [Abstract][Full Text] [Related]
19. Repair of osteochondral defects in a rabbit model using a porous hydroxyapatite collagen composite impregnated with bone morphogenetic protein-2.
Taniyama T; Masaoka T; Yamada T; Wei X; Yasuda H; Yoshii T; Kozaka Y; Takayama T; Hirano M; Okawa A; Sotome S
Artif Organs; 2015 Jun; 39(6):529-35. PubMed ID: 25865039
[TBL] [Abstract][Full Text] [Related]
20. Systemic Administration of Sclerostin Antibody Enhances Bone Morphogenetic Protein-Induced Femoral Defect Repair in a Rat Model.
Tinsley BA; Dukas A; Pensak MJ; Adams DJ; Tang AH; Ominsky MS; Ke HZ; Lieberman JR
J Bone Joint Surg Am; 2015 Nov; 97(22):1852-9. PubMed ID: 26582615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
